IDCs have significant clinical implications, particularly in the context of immunotherapy and transplantation. Their ability to present antigens and activate T-cells makes them potential targets for cancer immunotherapies. Furthermore, understanding the behavior of IDCs can aid in the development of strategies to induce immune tolerance, which is crucial for preventing graft rejection in organ transplantation.
